These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28446142)
41. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Rezania K; Gundogdu B; Soliven B Front Biosci; 2004 Jan; 9():939-45. PubMed ID: 14766420 [TBL] [Abstract][Full Text] [Related]
42. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies. Viala K Int J Neurosci; 2016 Sep; 126(9):777-85. PubMed ID: 26392214 [TBL] [Abstract][Full Text] [Related]
45. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494 [TBL] [Abstract][Full Text] [Related]
46. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Hughes RA; Allen D; Makowska A; Gregson NA J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780 [TBL] [Abstract][Full Text] [Related]
47. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. Madia F; Frisullo G; Nociti V; Conte A; Luigetti M; Del Grande A; Patanella AK; Iorio R; Tonali PA; Batocchi AP; Sabatelli M J Peripher Nerv Syst; 2009 Jun; 14(2):107-17. PubMed ID: 19691533 [TBL] [Abstract][Full Text] [Related]
48. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients. Mrad M; Fekih-Mrissa N; Mansour M; Seyah A; Riahi A; Gritli N; Mrissa R Transfus Apher Sci; 2013 Dec; 49(3):623-6. PubMed ID: 23968987 [TBL] [Abstract][Full Text] [Related]
49. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Faucard R; Madeira A; Gehin N; Authier FJ; Panaite PA; Lesage C; Burgelin I; Bertel M; Bernard C; Curtin F; Lang AB; Steck AJ; Perron H; Kuntzer T; Créange A EBioMedicine; 2016 Apr; 6():190-198. PubMed ID: 27211560 [TBL] [Abstract][Full Text] [Related]
50. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477 [TBL] [Abstract][Full Text] [Related]
51. Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. Chi LJ; Xu WH; Zhang ZW; Huang HT; Zhang LM; Zhou J J Peripher Nerv Syst; 2010 Dec; 15(4):345-56. PubMed ID: 21199106 [TBL] [Abstract][Full Text] [Related]
52. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin. Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080 [TBL] [Abstract][Full Text] [Related]
53. Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses. Klehmet J; Hoffmann S; Walter G; Meisel C; Meisel A J Neurol Sci; 2016 Sep; 368():77-83. PubMed ID: 27538605 [TBL] [Abstract][Full Text] [Related]
54. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416 [TBL] [Abstract][Full Text] [Related]
55. Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity. Stascheit F; Hotter B; Klose S; Meisel C; Meisel A; Klehmet J Front Neurol; 2021; 12():723009. PubMed ID: 34589050 [No Abstract] [Full Text] [Related]
56. High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients. Gladstone DE; Golightly MG; Brannagan TH J Neuroimmunol; 2007 Oct; 190(1-2):121-6. PubMed ID: 17854912 [TBL] [Abstract][Full Text] [Related]